Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No.241 Huaihai West Rd, Shanghai, 200030, China.
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No.241 Huaihai West Rd, Shanghai, 200030, China.
World J Surg. 2023 Dec;47(12):3240-3249. doi: 10.1007/s00268-023-07190-3. Epub 2023 Oct 4.
This study aimed to investigate the potential of a combined score based on CYFRA 21-1 level and LMR as a prognostic predictor for patients with ESCC.
A total of 460 patients who underwent esophagectomy were analyzed, and three groups were established based on the CA-LMR score. OS and RFS were evaluated using the Kaplan-Meier analysis, and associated factors were analyzed by univariate and multivariate Cox analysis. A mpStage system was also established based on the CA-LMR score.
The allocation of CA-LMR score of 0, 1, and 2 was 107 (23.3%), 280 (60.9%), and 73 (15.9%). There was a significant association between CA-LMR and male gender (P = 0.001), lower BMI (P = 0.035), longer tumor lesions (P = 0.002), and high pT, pN, pStage (P < 0.001, P = 0.011, P = 0.001). The 5-year OS rates for CA-LMR scores of 0, 1, and 2 were 75.4%, 60.2%, and 32.8%, respectively (P < 0.001). Multivariate analysis showed that CA-LMR score (P = 0.011) was an independent prognostic factor for OS. The proposed mpStage system, based on CA-LMR score, demonstrated superior discriminatory ability, monotonicity, homogeneity, and prognosis prediction ability over AJCC 8th pStage system.
The CA-LMR score, combined with tumor marker and inflammatory index, could use as a potential prognostic indicator; moreover, our modified pStage system exhibited superior stratification and prognostic accuracy for patients with ESCC.
本研究旨在探讨基于 CYFRA 21-1 水平和 LMR 的联合评分作为 ESCC 患者预后预测指标的潜力。
对 460 例行食管切除术的患者进行分析,根据 CA-LMR 评分将患者分为三组。采用 Kaplan-Meier 分析评估 OS 和 RFS,并采用单因素和多因素 Cox 分析分析相关因素。还根据 CA-LMR 评分建立了 mpStage 系统。
CA-LMR 评分 0、1 和 2 的分配分别为 107(23.3%)、280(60.9%)和 73(15.9%)。CA-LMR 与男性性别(P=0.001)、较低的 BMI(P=0.035)、较长的肿瘤病变(P=0.002)和较高的 pT、pN、pStage 显著相关(P<0.001,P=0.011,P=0.001)。CA-LMR 评分 0、1 和 2 的 5 年 OS 率分别为 75.4%、60.2%和 32.8%(P<0.001)。多因素分析表明,CA-LMR 评分(P=0.011)是 OS 的独立预后因素。基于 CA-LMR 评分的提出的 mpStage 系统在判别能力、单调性、同质性和预后预测能力方面均优于第 8 版 AJCC pStage 系统。
CA-LMR 评分结合肿瘤标志物和炎症指标可作为潜在的预后指标;此外,我们改良的 pStage 系统对 ESCC 患者具有更好的分层和预后准确性。